Recent advances in probiotics as live biotherapeutics against gastrointestinal diseases.
CONCLUSIONS: Several reports and clinical trials point out to the beneficial effects of probiotics in modulating the gut microbiota and improving the side effects of gastrointestinal diseases. Live biotherapeutics and FMT's could be suitable and successful alternatives to conventional therapies in mitigating the gastrointestinal pathogens.
PMID: 30014799 [PubMed - as supplied by publisher]
Source: Current Pharmaceutical Design - Category: Drugs & Pharmacology Authors: Kota RK, Ambati RR, Yalakurthi AK, Srirama K, Reddy PN Tags: Curr Pharm Des Source Type: research
More News: Autoimmune Disease | Clinical Trials | Drugs & Pharmacology | Dysentery | Economy | Emergency Medicine | Gastroenterology | Parasitic Diseases | Parasitology | Probiotics | Transplants